Timothy J. Shelly - 11 Nov 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Signature
/s/ Timothy J. Shelly
Issuer symbol
NHC
Transactions as of
11 Nov 2025
Net transactions value
-$215,005
Form type
4
Filing time
13 Nov 2025, 17:25:58 UTC
Previous filing
26 Feb 2025
Next filing
18 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shelly Timothy J. Sr.VP Operations 100 VINE STREET, MURFREESBORO /s/ Timothy J. Shelly 13 Nov 2025 0002031428

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Common Stock Options Exercise $153,504 +2,400 $63.96 2,400 11 Nov 2025 Direct F1
transaction NHC Common Stock Tax liability $218,791 -1,655 -69% $132.20 745 11 Nov 2025 Direct F3
transaction NHC Common Stock Options Exercise $258,912 +4,800 +644% $53.94 5,545 11 Nov 2025 Direct F2
transaction NHC Common Stock Tax liability $408,630 -3,091 -56% $132.20 2,454 11 Nov 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise $0 -2,400 -100% $0.000000 0 11 Nov 2025 Common Stock 2,400 $63.96 Direct F1
transaction NHC Option to Purchase Common Stock Options Exercise $0 -4,800 -67% $0.000000 2,400 11 Nov 2025 Common Stock 7,200 $53.94 Direct F2
holding NHC Option to Purchase Common Stock 8,000 11 Nov 2025 Common Stock 8,000 $94.10 Direct
holding NHC Option to Purchase Common Stock 11,000 11 Nov 2025 Common Stock 11,000 $90.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F3 Shares were withheld by the Company to pay the exercise price and withholding tax obligations.